Moderna Expects Vaccine Data For Kids Ages 2-5 By March

January 12, 2022, 06:40pm.

Modern hopes to report data on the effectiveness of its Covid-19 vaccine in children ages 2 to 5 by March, and hopes to evaluate its booster shot for those ages 12 to 17 as Covid-related hospitalizations for children have reached record levels.

A young boy gets a vaccine at a health centre in Glasgow. Medical experts believe that the vaccine is safe and that it does not cause autism. Jeff J Mitchell is the photographer.

The images are from the same company.

The company will proceed with regulatory filings if the data from the 2 to 5 age group trials is promising.

The FDA has yet to approve any Covid-19 vaccine for children under the age of 5, with only Pfizer's vaccine authorized for those ages 5 to 11.
Moderna said it has been evaluating a booster dose for the age group despite not having its initial two-dose vaccine approved.

Moderna's has received authorizations in Europe, Australia and Canada, but Pfizer's is the only vaccine approved for those ages 12 to 17 in the US.

The FDA told Moderna in October that it needed more time to assess the company's vaccine before approving it for adolescents.
Moderna began evaluating a lower dosage for the 6-to-11 and 12- to 17 age groups in order to meet regulatory guidance.

Pfizer is conducting trials on the efficacy of its Covid-19 vaccine for children ages 2 to 5 and babies 6 months to 2 years. In December, it was announced that the vaccine was not as effective in young children as it was in older children, but it was still effective in the 6 to 24 month group. The company said it would evaluate the efficacy of a third dose in an attempt to reach the desired immunity in this group, as well as a third dose for children ages 5 to 12.

7 million. According to the CDC, 25% of all 5- to 11-year-olds in the US have received at least one dose of the Covid-19 vaccine. The rate of admissions for Covid-related children increased last week.
Chief critic.

The age group's low vaccination rates are very disturbing, according to Robert Murphy, executive director for the Institute for Global Health at the Feinberg School of Medicine. Murphy said that some parents are taking an enormous risk by not knowing if their children will have a severe reaction to the virus.

It's time to expand the vaccine for toddlers and infants.

The U.S. has set a new record in hospitalizations.

Coverage and live updates on the coronaviruses.